Literature DB >> 33348669

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.

Ajda Taler-Verčič1, Marko Goličnik1, Aljoša Bavec1.   

Abstract

n class="Chemical">Serum n>n class="Gene">paraoxonase-1 (PON1) is the most studied member of the group of paraoxonases (PONs). This enzyme possesses three enzymatic activities: lactonase, arylesterase, and paraoxonase activity. PON1 and its isoforms play an important role in drug metabolism as well as in the prevention of cardiovascular and neurodegenerative diseases. Although all three members of the PON family have the same origin and very similar amino acid sequences, they have different functions and are found in different locations. PONs exhibit substrate promiscuity, and their true physiological substrates are still not known. However, possible substrates include homocysteine thiolactone, an analogue of natural quorum-sensing molecules, and the recently discovered derivatives of arachidonic acid-bioactive δ-lactones. Directed evolution, site-directed mutagenesis, and kinetic studies provide comprehensive insights into the active site and catalytic mechanism of PON1. However, there is still a whole world of mystery waiting to be discovered, which would elucidate the substrate promiscuity of a group of enzymes that are so similar in their evolution and sequence yet so distinct in their function.

Entities:  

Keywords:  PON1; PON2; PON3; arylesterase; atherosclerosis; kinetic; lactonase; organophosphate; oxidative stress; paraoxonase; structure

Year:  2020        PMID: 33348669     DOI: 10.3390/molecules25245980

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  9 in total

1.  Bioactivation and detoxification of organophosphorus pesticides in freshwater planarians shares similarities with humans.

Authors:  Danielle Ireland; Christina Rabeler; TaiXi Gong; Eva-Maria S Collins
Journal:  Arch Toxicol       Date:  2022-09-29       Impact factor: 6.168

2.  Evaluation of Oxidative Status in Elderly Patients with Multiple Cerebral Infarctions and Multiple Chronic Total Coronary Occlusions.

Authors:  Xia Li; Dianxuan Guo; Youdong Hu; Ying Chen
Journal:  Dis Markers       Date:  2022-06-28       Impact factor: 3.464

Review 3.  Paraoxonase-1 Concentrations in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis.

Authors:  Maria Carmina Pau; Angelo Zinellu; Elisabetta Zinellu; Gianfranco Pintus; Ciriaco Carru; Alessandro G Fois; Arduino A Mangoni; Pietro Pirina
Journal:  Antioxidants (Basel)       Date:  2022-04-12

Review 4.  Human Paraoxonase-2 (PON2): Protein Functions and Modulation.

Authors:  Giuseppe Manco; Elena Porzio; Teresa Maria Carusone
Journal:  Antioxidants (Basel)       Date:  2021-02-07

5.  Insights into the role of paraoxonase 2 in human pathophysiology.

Authors:  Fauzia Parween; Rinkoo Devi Gupta
Journal:  J Biosci       Date:  2022       Impact factor: 1.826

6.  Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer's disease.

Authors:  Fauzia Parween; Md Summon Hossain; Kshetra Pal Singh; Rinkoo Devi Gupta
Journal:  PLoS One       Date:  2021-10-29       Impact factor: 3.240

7.  Changes in serum pigment epithelium-derived factor levels after kidney transplantation in patients with end-stage renal disease.

Authors:  Réka Szentimrei; Hajnalka Lőrincz; Anita Szentpéteri; Viktória E Varga; Mariann Harangi; Ildikó Seres; Réka P Szabó; Balázs Nemes; György Paragh
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 8.  Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs.

Authors:  Kush K Patel; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2021-06-12       Impact factor: 5.858

9.  S-Nitrosylation of Paraxonase 1 (PON1) Elevates Its Hydrolytic and Antioxidant Activities.

Authors:  Hanin Hajouj; Ali Khattib; Dana Atrahimovich; Sanaa Musa; Soliman Khatib
Journal:  Biomolecules       Date:  2022-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.